Espínola, N. et al. 2024. Budget impact of upadacitinib in patients with moderate to severe rheumatoid arthritis in Argentina. Revista Peruana de Medicina Experimental y Salud Pública. 41, 2 (Jun. 2024), 129–38. DOI:https://doi.org/10.17843/rpmesp.2024.412.12934.